List view / Grid view

Ganymed Pharmaceuticals AG

 

news

IMAB362 extends survival in gastric cancer

6 June 2016 | By Victoria White, Digital Content Producer

Ganymed announced data from its randomised Phase II clinical study of IMAB362 in first-line treatment of gastric cancer at the ASCO 2016 Annual Meeting...